<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.business-standard.com/article/pti-stories/sparc-q2-loss-widens-to-rs-63-cr-119110400741_1.html"/>
    <meta property="og:site_name" content="Business-Standard"/>
    <meta property="article:published_time" content="2019-11-04T09:30:00+00:00"/>
    <meta property="og:title" content="SPARC's Sept quarter loss widens to Rs 63 cr from Rs 2.58 cr last year"/>
    <meta property="og:description" content="Shares of SPARC were trading at Rs 146.7 apiece, up 2.34% on the BSE"/>
  </head>
  <body>
    <article>
      <h1>SPARC's Sept quarter loss widens to Rs 63 cr from Rs 2.58 cr last year</h1>
      <h2>Shares of SPARC were trading at Rs 146.7 apiece, up 2.34% on the BSE</h2>
      <address><time datetime="2019-11-04T09:30:00+00:00">04 Nov 2019, 09:30</time> by <a rel="author">Press Trust of India</a></address>
      <p>Sun Pharma Advanced Research Company (SPARC) on Monday reported a net loss of Rs 63.16 crore for the quarter ended September 30 of the ongoing fiscal.</p>
      <p>The company had reported a loss of Rs 2.58 crore for July-September, 2018-19.</p>
      <p>Total income declined to Rs 19.45 crore during the second quarter as compared with Rs 65.92 crore in the year-ago period, <a href="https://www.business-standard.com/topic/sparc">SPARC </a>said in a regulatory filing.</p>
      <p>Shares of <a href="https://www.business-standard.com/topic/sparc">SPARC </a>were trading at Rs 146.7 apiece, up 2.34 per cent on the BSE.</p>
    </article>
  </body>
</html>